Stock ROG ROCHE HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
 03:34:51 2024-04-16 am EDT 		5-day change 1st Jan Change
223.2 CHF -0.87% Intraday chart for Roche Holding AG +1.04% -8.34%
11:41am ROCHE HOLDINGS AG : JP Morgan reiterates its Sell rating ZD
08:05am Roche: positive phase III data in lymphoma CF

Business Summary

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees: 103,605

Sales per Business

CHF in Million2022Weight2023Weight Delta
Pharmaceuticals
76.6 %
48,628 73.2 % 46,279 76.6 % -4.83%
Diagnostics
23.4 %
17,798 26.8 % 14,162 23.4 % -20.43%

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
46.9 %
29,313 44.1 % 28,352 46.9 % -3.28%
Rest of Europe
16.1 %
10,328 15.5 % 9,703 16.1 % -6.05%
Rest of Asia
14.7 %
9,852 14.8 % 8,890 14.7 % -9.76%
Japan
7.4 %
6,452 9.7 % 4,464 7.4 % -30.81%
Latin America
4.9 %
2,870 4.3 % 2,971 4.9 % +3.52%
Germany
4.8 %
3,318 5.0 % 2,893 4.8 % -12.81%
Africa, Australia and Oceania
2.0 %
1,520 2.3 % 1,212 2.0 % -20.26%
Switzerland
1.8 %
1,671 2.5 % 1,118 1.8 % -33.09%
Rest of North America
1.4 %
1,102 1.7 % 838 1.4 % -23.96%

Managers

Managers TitleAgeSince
Thomas Schinecker CEO
 Chief Executive Officer 49 02-12-31
Severin Schwan CHM
 Chairman 57 07-12-31
Alan Hippe DFI
 Director of Finance/CFO 57 11-03-31
Pascale Schmidt CMP
 Compliance Officer 51 19-12-31
Levi Garraway CTO
 Chief Tech/Sci/R&D Officer - -
Bruno Eschli IRC
 Investor Relations Contact - -
Silke Hörnstein PRN
 Corporate Officer/Principal 49 14-12-31
Annette Luther SEC
 Corporate Secretary 54 20-03-31
Claudia Boeckstiegel LAW
 General Counsel 60 20-03-31
Cristina A. Wilbur HRO
 Human Resources Officer 57 -

Members of the board

Members of the board TitleAgeSince
Bernard Poussot BRD
 Director/Board Member 72 15-03-02
Ulf Mark Schneider BRD
 Director/Board Member 59 -
André S. Hoffmann BRD
 Director/Board Member 65 95-12-31
Patrick Frost BRD
 Director/Board Member 56 20-03-16
Hans Clevers PRN
 Corporate Officer/Principal 67 19-03-04
Severin Schwan CHM
 Chairman 57 07-12-31
Anita Hauser BRD
 Director/Board Member 55 17-03-13
Richard P. Lifton BRD
 Director/Board Member 71 15-03-02
Claudia Dyckerhoff BRD
 Director/Board Member 58 16-02-29
Joerg Duschmale BRD
 Director/Board Member 40 20-03-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,691,000 28,989,189 ( 27.17 %) 0 88.91 %
Stock B 1 702,562,700 690,550,124 ( 98.29 %) 12,011,755 ( 1.710 %)

Shareholders

NameEquities%Valuation
ROCHE HOLDING AG
1.434 %
10,073,029 1.434 % 2 569 M CHF
MFS International (UK) Ltd.
0.5987 %
4,206,054 0.5987 % 1 073 M CHF
Swedbank Robur Fonder AB
0.3107 %
2,182,825 0.3107 % 557 M CHF
March Asset Management SGIIC SAU
0.2754 %
1,934,990 0.2754 % 493 M CHF
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2340 %
1,644,320 0.2340 % 419 M CHF
MFS International Singapore Pte. Ltd.
0.2249 %
1,579,717 0.2249 % 403 M CHF
State Street Global Advisors Ltd.
0.2145 %
1,506,837 0.2145 % 384 M CHF
CapitalatWork SA
0.1965 %
1,380,872 0.1965 % 352 M CHF
Swisscanto Fondsleitung AG
0.1907 %
1,339,459 0.1907 % 342 M CHF
Nordea Investment Management AB
0.1879 %
1,320,423 0.1879 % 337 M CHF
NameEquities%Valuation
MFS Investment Management Canada Ltd.
0.0493 %
2,768,432 0.0493 % 88 M CHF
Saratoga Research & Investment Management
0.0409 %
2,300,436 0.0409 % 73 M CHF
Pacer Advisors, Inc.
0.0196 %
1,099,659 0.0196 % 35 M CHF
NLG Capital, Inc.
0.0129 %
724,880 0.0129 % 23 M CHF
Van Kampen Asset Management
0.009381 %
527,280 0.009381 % 17 M CHF
Financial Gravity Asset Management, Inc.
0.009207 %
517,463 0.009207 % 17 M CHF
MFS International (UK) Ltd.
0.008446 %
474,717 0.008446 % 15 M CHF
Boston Common Asset Management LLC
0.008147 %
457,875 0.008147 % 15 M CHF
Truffle Asset Management (Pty) Ltd.
0.004877 %
274,100 0.004877 % 9 M CHF
Old National Bank (Investment Management)
0.004346 %
244,290 0.004346 % 8 M CHF
NameEquities%Valuation
Hoffmann Family
64.97 %
69,318,000 64.97 % 18 701 M CHF
Maja Oeri
7.584 %
8,091,900 7.584 % 2 183 M CHF
Severin Schwan
0.2294 %
244,786 0.2294 % 66 M CHF
Rothschild & Co. Bank AG
0.1893 %
202,000 0.1893 % 54 M CHF
Ignis Investment Services Ltd.
0.1660 %
177,114 0.1660 % 48 M CHF
Goldman Sachs Advisors BV
0.1574 %
167,973 0.1574 % 45 M CHF
Pareto Asset Management AS
0.1492 %
159,150 0.1492 % 43 M CHF
zCapital AG
0.1087 %
116,000 0.1087 % 31 M CHF
ODDO BHF Trust GmbH
0.0964 %
102,850 0.0964 % 28 M CHF
Aberdeen Standard Investments (Japan) Ltd.
0.0540 %
57,600 0.0540 % 16 M CHF

Holdings

NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD
59.89%
 1,005,670,000 59.89% 38,367,557,531 $
ROCHE HOLDING AG
1.43%
 10,073,029 1.43% 2,568,862,838 $
ENTRADA THERAPEUTICS, INC.
8.17%
 2,744,120 8.17% 38,884,180 $
JASPER THERAPEUTICS, INC.
3.02%
 454,961 3.02% 13,357,655 $
ALIGOS THERAPEUTICS, INC.
15.19%
 11,025,941 15.19% 10,805,422 $
ELOXX PHARMACEUTICALS, INC.
0.06%
 1,893 0.06% 1,893 $

Company contact information

Roche Holding AG

Grenzacherstrasse 124

4058, Basel

+41 61 688 11 11

http://www.roche.com
address Roche Holding AG(ROG)

Group companies

NameCategory and Sector
Sapac Corp. Ltd.
Roche Pharmholding BV
Logo Roche Pharmholding BV

Roche Pharmholding BV

Medical DistributorsDistribution Services

Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The private company is based in Woerden, Netherlands.

Medical Distributors
Roche Finance Europe BV
Finance/Rental/Leasing
Roche Catalyst Investments Ltd.
Roche Financial Investments Ltd.
Roche Intertrade Ltd.
Roche Diagnostics India Pvt Ltd.
Logo Roche Diagnostics India Pvt Ltd.

Roche Diagnostics India Pvt Ltd.

Medical SpecialtiesHealth Technology

Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The private company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers.

Medical Specialties
Viewics India Pvt Ltd.
Roche Financial Management Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225 CHF
Average target price
281.3 CHF
Spread / Average Target
+25.01%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ROCHE HOLDING AG Stock Roche Holding AG
-7.98% 199B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.94% 677B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.41% 560B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.88% 355B
ABBVIE INC. Stock AbbVie Inc.
+4.72% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.69% 214B
NOVARTIS AG Stock Novartis AG
+1.47% 207B
PFIZER, INC. Stock Pfizer, Inc.
-10.18% 146B
AMGEN INC. Stock Amgen Inc.
-7.20% 143B
SANOFI Stock Sanofi
-1.88% 115B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ROG Stock
  4. Company Roche Holding AG